These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36359499)

  • 1. Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation.
    Mantica G; Suardi N; Smelzo S; Esperto F; Chierigo F; Tappero S; Borghesi M; La Rocca R; Oderda M; Ennas M; Stabile A; De Cobelli F; Napolitano L; Papalia R; Gontero P; Introini C; Briganti A; Scarpa RM; Mirone V; Montorsi F; Gaboardi F; Terrone C; Cardone G
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36359499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teaching Urologists "How to Read Multi-Parametric Prostate MRIs Using PIRADSv2": Results of an iBook Pilot Study.
    Wang NN; Fan RE; Ghanouni P; Sonn GA
    Urology; 2019 Sep; 131():40-45. PubMed ID: 31150691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
    Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
    Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between 1.5 and 3 Tesla multiparametric MRI systems using the PIRADS version 2 classification in the diagnosis of prostate cancer.
    Cabello MÁR; Rubio SM; Sanz ÁM; Miguelañez JLS; Alba DV; González CA; Sancho AP
    Arch Esp Urol; 2022 May; 75(4):330-338. PubMed ID: 35818913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA.
    Müller S; Lilleaasen G; Sand TE; Løfsgaard L; Estop-Garanto M; Helgø D; Sund P; Mygland V
    World J Urol; 2018 May; 36(5):687-691. PubMed ID: 29508048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
    Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
    Muller BG; van den Bos W; Brausi M; Cornud F; Gontero P; Kirkham A; Pinto PA; Polascik TJ; Rastinehad AR; de Reijke TM; de la Rosette JJ; Ukimura O; Villers A; Walz J; Wijkstra H; Marberger M
    BJU Int; 2014 Nov; 114(5):698-707. PubMed ID: 24180365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.
    Rastinehad AR; Waingankar N; Turkbey B; Yaskiv O; Sonstegard AM; Fakhoury M; Olsson CA; Siegel DN; Choyke PL; Ben-Levi E; Villani R
    PLoS One; 2015; 10(11):e0143404. PubMed ID: 26605548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding tumor localization in multiparametric MRI of the prostate-effectiveness of 3D printed models.
    Haack M; Reisen K; Ghazy A; Stroh K; Frey L; Sparwasser P; Duwe G; Mager R; Haferkamp A; Borgmann H
    Front Surg; 2023; 10():1264164. PubMed ID: 37799119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes and perceptions towards multiparametric magnetic resonance imaging of the prostate: A national survey among Italian urologists.
    Stanzione A; Creta M; Imbriaco M; La Rocca R; Capece M; Esposito F; Imbimbo C; Fusco F; Celentano G; Napolitano L; Mangiapia F; Mirone V; Longo N
    Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
    Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
    Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: Real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized.
    Bertolo R; Vittori M; Cipriani C; Maiorino F; Forte V; Iacovelli V; Petta F; Sperandio M; Marani C; Panei M; Travaglia S; Bove P
    Prog Urol; 2021 Oct; 31(12):739-746. PubMed ID: 33431200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive value of mpMRI on prostate cancer detection: Comparison between patients with and without a suspicious digital rectal examination (DRE).
    Omri N; Alex S; Jacob B; Ofer N
    Urol Oncol; 2021 Oct; 39(10):728.e7-728.e11. PubMed ID: 33454199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series.
    Barletta F; Stabile A; Mazzone E; Brembilla G; Sorce G; Pellegrino F; Scuderi S; Cannoletta D; Cirulli GO; Cucchiara V; Gandaglia G; De Cobelli F; Montorsi F; Briganti A
    Urol Oncol; 2022 Mar; 40(3):103.e17-103.e24. PubMed ID: 34688534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    Gan JM; Kikano EG; Smith DA; Rao S; Podury R; Wang M; Durieux JC; Paspulati RM; Ponsky L; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 May; 218(5):859-866. PubMed ID: 34817189
    [No Abstract]   [Full Text] [Related]  

  • 18. A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
    Sönmez G; Tombul ŞT; Demirtaş T; Öztürk F; Demirtaş A
    Cureus; 2019 Dec; 11(12):e6329. PubMed ID: 31857929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative standardized reporting template for prostate mpMRI improves clarity and confidence in the report.
    Caputo JM; Pina LA; Sebesta EM; Shaish H; Wenske S
    World J Urol; 2021 Jul; 39(7):2447-2452. PubMed ID: 33079251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
    Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
    Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.